Valeant Pharma (VRX) Releases Slides Ahead of Investor Conference Call
Tweet
Share
E-mailGet Alerts VRX Hot Sheet
Price: $23.40 --0%
Financial Fact:
Net income per share attributable to Valeant: 0.39
Today's EPS Names:
CCEL, SLP, TMQ, More
Financial Fact:
Net income per share attributable to Valeant: 0.39
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Valeant Pharma (NYSE: VRX) released the slides for its upcoming 8AM conference to address concerns about its relationship an use of specialty pharmacies.
The slides don't appear to address today's new revelation from the Wall Street Journal that employees of Philidor also worked at Valeant and used alternative names in e-mails.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy rejects short-seller report on finances and supply chain
- Alignment Healthcare: Allegations Are Wholly Without Merit - Bloomberg
- Hunterbrook is short Bloom Energy
Create E-mail Alert Related Categories
Conference Calls, Momentum Movers, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
